See Disclaimer regarding information on this site. Some links on this page may take you to organizations outside of the National Institutes of Health.
salivary glands. Salivary gland cancer is diagnosed in 2-3 individuals per 100,000 people each year, and 30-35% of these are mucoepidermoid carcinomas. Mucoepidermoid carcinoma develops when a cell randomly acquires changes (mutations) in genes that regulate how the cell divides such that it begins to grow quickly, forming a cluster of cells (a mass or lump). The earliest signs of a mucoepidermoid carcinoma may include a lump in the face, neck, or mouth; numbness, weakness, or pain in part of the face; or difficulty swallowing. Treatment often begins with surgery to remove the entire tumor. In some cases, radiation therapy and/or chemotherapy may be used after surgery to ensure that no cancer cells remain in the body.Mucoepidermoid carcinoma is a type of cancer of the
Last updated: 6/18/2013
- Chandana SR, Conley BA. Salivary gland cancers: current treatments, molecular characteristics and new therapies.. Expert Review of Anticancer Therapy. 2008; 8:645-652. http://www.ncbi.nlm.nih.gov/pubmed/18402531. Accessed 8/3/2011.
- American Cancer Society. Salviary Gland Cancer. Learn About Cancer. 2011; http://www.cancer.org/Cancer/SalivaryGlandCancer/DetailedGuide/salivary-gland-cancer-what-is-salivary-gland-cancer. Accessed 8/3/2011.
On this page
- Medscape Reference provides information on this topic. You may need to register to view the medical textbook, but registration is free.